William Mack & Associates
IDXX icon

William Mack & Associates’s Idexx Laboratories IDXX Stock Holding History

William Mack & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04K Buy
+2
New +$1.1K ﹤0.01% 724

Other funds holding IDXX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

William Mack & Associates's IDXX Position: Q3 2026 in Review

William Mack & Associates opened a new position in Idexx Laboratories (IDXX) in Q3 2026: 2 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #724 among its holdings.

1,073 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • William Mack & Associates held 2 shares of Idexx Laboratories worth $1.04K as of Q3 2026.
  • Idexx Laboratories was a new William Mack & Associates position in Q3 2026.
  • Idexx Laboratories made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #724 holding.
  • 1,073 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.